S&P Futures
4,335.25 -2.25 (-0.05%) Dow Futures
33,904.00 +12.00 (+0.04%) Nasdaq Futures
14,854.00 -5.75 (-0.04%) Russell 2000 Futures
1,808.00 -1.10 (-0.06%) Crude Oil
91.72 +0.01 (+0.01%) Gold
1,883.80 +5.20 (+0.28%)
After hours:
Chart Events
Performance Outlook
| Previous Close | 49.96 |
| Open | 50.07 |
| Bid | 49.25 x 800 |
| Ask | 51.25 x 800 |
| Day's Range | 49.90 - 50.74 |
| 52 Week Range | 48.86 - 80.04 |
| Volume | |
| Avg. Volume | 1,709,885 |
| Market Cap | 7.024B |
| Beta (5Y Monthly) | 1.08 |
| PE Ratio (TTM) | 24.88 |
| EPS (TTM) | 2.02 |
| Earnings Date | Nov 06, 2023 - Nov 10, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 66.36 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for GMED
Related Research
- Globus Medical, Inc.GMED: Lowering target price to $52.00GLOBUS MEDICAL INC - A has an Investment Rating of HOLD; a target price of $52.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.RatingFair ValueEconomic Moat2 days agoArgus Research
GlobeNewswireGlobus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
AUDUBON, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it will continue its partnership with EUROSPINE as a silver sponsor and will attend EUROSPINE 2023 held October 4 to 6 in Frankfurt. “As leaders in the musculoskeletal device industry, we are committed to procedurally integrated innovation that enables surgeons to deliver more intelligent surgery,” said Dan Scavilla, chief executive officer at Globus Me
The FlyDell upgraded, Starbucks downgraded: Wall Street's top analyst calls
Dell upgraded, Starbucks downgraded: Wall Street's top analyst calls
- Investing.com
Dell a buy on AI and bolstered demand: 5 big analyst picks
Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: an Overweight initiation for Super Micro Computer, and upgrades for Dell, CVS, Globus Medical , and Rackspace Technology. Dell (NYSE:DELL) shares were rising nearly 2% pre-market Tuesday after Daiwa Securities upgraded the PC maker to Outperform from Neutral and raised its price target to $80.00 from $50.00, as reported in real time on InvestingPro. The analysts noted that Dell's Q2/24 earnings report last month exceeded consensus expectations with strong revenue of $22.9 billion, which beat estimates by $2.1B.
